

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication-dependent nucleosome organization (GO:0034723) | 7.52814528 |
| 2 | DNA replication-dependent nucleosome assembly (GO:0006335) | 7.52814528 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 7.27144792 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 5.95690143 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.83425104 |
| 6 | chromatin assembly (GO:0031497) | 5.77105166 |
| 7 | regulation of histone H3-K9 methylation (GO:0051570) | 5.64494416 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 5.49485492 |
| 9 | nucleosome assembly (GO:0006334) | 5.49277967 |
| 10 | regulation of platelet aggregation (GO:0090330) | 5.30073375 |
| 11 | mucosal immune response (GO:0002385) | 5.08285306 |
| 12 | protein localization to kinetochore (GO:0034501) | 5.04876809 |
| 13 | nuclear pore complex assembly (GO:0051292) | 4.96808112 |
| 14 | chromatin assembly or disassembly (GO:0006333) | 4.96655239 |
| 15 | nuclear pore organization (GO:0006999) | 4.96451985 |
| 16 | organ or tissue specific immune response (GO:0002251) | 4.80388200 |
| 17 | nucleosome organization (GO:0034728) | 4.74334969 |
| 18 | regulation of platelet activation (GO:0010543) | 4.74090165 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 4.73103916 |
| 20 | protein-DNA complex assembly (GO:0065004) | 4.72334555 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71711699 |
| 22 | DNA replication initiation (GO:0006270) | 4.70227512 |
| 23 | mitotic chromosome condensation (GO:0007076) | 4.67408629 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.65081802 |
| 25 | protein neddylation (GO:0045116) | 4.62549692 |
| 26 | neutrophil activation (GO:0042119) | 4.62243063 |
| 27 | platelet aggregation (GO:0070527) | 4.59903003 |
| 28 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.57715247 |
| 29 | viral transcription (GO:0019083) | 4.53388217 |
| 30 | CENP-A containing nucleosome assembly (GO:0034080) | 4.52388311 |
| 31 | chromatin remodeling at centromere (GO:0031055) | 4.52345162 |
| 32 | DNA strand elongation (GO:0022616) | 4.42733989 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.42668945 |
| 34 | translational termination (GO:0006415) | 4.41854906 |
| 35 | protein localization to chromosome, centromeric region (GO:0071459) | 4.37260737 |
| 36 | blood coagulation, intrinsic pathway (GO:0007597) | 4.36123410 |
| 37 | protein-DNA complex subunit organization (GO:0071824) | 4.21291087 |
| 38 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.20941299 |
| 39 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.20284990 |
| 40 | sister chromatid segregation (GO:0000819) | 4.18014412 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 4.15770495 |
| 42 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.15730215 |
| 43 | antibacterial humoral response (GO:0019731) | 4.15283772 |
| 44 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 4.11607070 |
| 45 | granulocyte activation (GO:0036230) | 4.08027300 |
| 46 | DNA replication-independent nucleosome assembly (GO:0006336) | 4.06469310 |
| 47 | DNA replication-independent nucleosome organization (GO:0034724) | 4.06469310 |
| 48 | mitotic recombination (GO:0006312) | 4.06208026 |
| 49 | adenosine receptor signaling pathway (GO:0001973) | 4.02711191 |
| 50 | lipoxygenase pathway (GO:0019372) | 4.01928295 |
| 51 | mitotic nuclear envelope disassembly (GO:0007077) | 4.01592654 |
| 52 | IMP biosynthetic process (GO:0006188) | 4.00593602 |
| 53 | translational elongation (GO:0006414) | 3.98159390 |
| 54 | telomere maintenance via recombination (GO:0000722) | 3.96387071 |
| 55 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.95085303 |
| 56 | positive regulation of macrophage differentiation (GO:0045651) | 3.93103236 |
| 57 | mitotic sister chromatid segregation (GO:0000070) | 3.92100582 |
| 58 | antimicrobial humoral response (GO:0019730) | 3.89254218 |
| 59 | innate immune response in mucosa (GO:0002227) | 3.88323536 |
| 60 | megakaryocyte development (GO:0035855) | 3.87515450 |
| 61 | pore complex assembly (GO:0046931) | 3.85388474 |
| 62 | DNA duplex unwinding (GO:0032508) | 3.81234151 |
| 63 | DNA geometric change (GO:0032392) | 3.81051072 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 3.78695908 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.78297574 |
| 66 | membrane disassembly (GO:0030397) | 3.77702636 |
| 67 | nuclear envelope disassembly (GO:0051081) | 3.77702636 |
| 68 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.77555906 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.75355624 |
| 70 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.75355624 |
| 71 | maturation of SSU-rRNA (GO:0030490) | 3.73044016 |
| 72 | kinetochore organization (GO:0051383) | 3.70906502 |
| 73 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.70433513 |
| 74 | negative regulation of norepinephrine secretion (GO:0010700) | 3.69103664 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.69096595 |
| 76 | IMP metabolic process (GO:0046040) | 3.67510855 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67114810 |
| 78 | ribosomal large subunit biogenesis (GO:0042273) | 3.64559898 |
| 79 | histone exchange (GO:0043486) | 3.60817539 |
| 80 | translational initiation (GO:0006413) | 3.59843354 |
| 81 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.56422173 |
| 82 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54805306 |
| 83 | negative regulation of platelet activation (GO:0010544) | 3.52814760 |
| 84 | cellular protein complex disassembly (GO:0043624) | 3.52728504 |
| 85 | DNA topological change (GO:0006265) | 3.49274590 |
| 86 | DNA replication checkpoint (GO:0000076) | 3.46977634 |
| 87 | telomere maintenance via telomere lengthening (GO:0010833) | 3.45456519 |
| 88 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.45084367 |
| 89 | protein targeting to ER (GO:0045047) | 3.44323818 |
| 90 | platelet degranulation (GO:0002576) | 3.43702678 |
| 91 | microglial cell activation (GO:0001774) | 3.43689295 |
| 92 | cotranslational protein targeting to membrane (GO:0006613) | 3.43451972 |
| 93 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.41926760 |
| 94 | translesion synthesis (GO:0019985) | 3.41854269 |
| 95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40847742 |
| 96 | regulation of integrin activation (GO:0033623) | 3.40825668 |
| 97 | leukocyte degranulation (GO:0043299) | 3.40723224 |
| 98 | meiotic chromosome segregation (GO:0045132) | 3.40325629 |
| 99 | homotypic cell-cell adhesion (GO:0034109) | 3.39882199 |
| 100 | viral life cycle (GO:0019058) | 3.39538924 |
| 101 | negative regulation of histone methylation (GO:0031061) | 3.39063609 |
| 102 | platelet formation (GO:0030220) | 3.36268817 |
| 103 | protein K6-linked ubiquitination (GO:0085020) | 3.36238195 |
| 104 | mitotic metaphase plate congression (GO:0007080) | 3.33980161 |
| 105 | positive regulation of receptor recycling (GO:0001921) | 3.33175817 |
| 106 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32902264 |
| 107 | regulation of gene silencing (GO:0060968) | 3.32722954 |
| 108 | dosage compensation (GO:0007549) | 3.32366647 |
| 109 | protein complex disassembly (GO:0043241) | 3.31466588 |
| 110 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.30769762 |
| 111 | angiogenesis involved in wound healing (GO:0060055) | 3.30609114 |
| 112 | regulation of mast cell degranulation (GO:0043304) | 3.29364654 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29125151 |
| 114 | negative regulation of cell killing (GO:0031342) | 3.29125151 |
| 115 | nucleobase biosynthetic process (GO:0046112) | 3.27847391 |
| 116 | telomere maintenance (GO:0000723) | 3.27063243 |
| 117 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.25687346 |
| 118 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24591479 |
| 119 | regulation of centriole replication (GO:0046599) | 3.24229065 |
| 120 | metaphase plate congression (GO:0051310) | 3.24180362 |
| 121 | telomere organization (GO:0032200) | 3.24149007 |
| 122 | regulation of spindle organization (GO:0090224) | 3.23903797 |
| 123 | regulation of centrosome cycle (GO:0046605) | 3.23387401 |
| 124 | platelet activation (GO:0030168) | 3.21784847 |
| 125 | positive regulation of chromosome segregation (GO:0051984) | 3.20288492 |
| 126 | DNA conformation change (GO:0071103) | 3.19779819 |
| 127 | negative regulation of T cell apoptotic process (GO:0070233) | 3.19378528 |
| 128 | myeloid cell activation involved in immune response (GO:0002275) | 3.18887778 |
| 129 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.18502217 |
| 130 | regulation of mast cell activation (GO:0033003) | 3.17703620 |
| 131 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.17479082 |
| 132 | protein localization to endoplasmic reticulum (GO:0070972) | 3.17445175 |
| 133 | positive regulation of blood coagulation (GO:0030194) | 3.16643414 |
| 134 | positive regulation of hemostasis (GO:1900048) | 3.16643414 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14556963 |
| 136 | regulation of translational fidelity (GO:0006450) | 3.14263274 |
| 137 | chromosome condensation (GO:0030261) | 3.13158148 |
| 138 | cellular extravasation (GO:0045123) | 3.11822128 |
| 139 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11335391 |
| 140 | postreplication repair (GO:0006301) | 3.11126459 |
| 141 | macromolecular complex disassembly (GO:0032984) | 3.09397505 |
| 142 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.09123747 |
| 143 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.08720226 |
| 144 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.06300020 |
| 145 | detection of other organism (GO:0098543) | 3.05823004 |
| 146 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05078864 |
| 147 | regulation of chromosome segregation (GO:0051983) | 3.04878852 |
| 148 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04130607 |
| 149 | spindle assembly checkpoint (GO:0071173) | 3.03761868 |
| 150 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.03719798 |
| 151 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.03719798 |
| 152 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.03719798 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03699505 |
| 154 | regulation of helicase activity (GO:0051095) | 3.03242588 |
| 155 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.03219492 |
| 156 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.02732653 |
| 157 | spindle checkpoint (GO:0031577) | 3.02614320 |
| 158 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.01604299 |
| 159 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01469011 |
| 160 | ATP-dependent chromatin remodeling (GO:0043044) | 3.00833244 |
| 161 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99448321 |
| 162 | establishment of chromosome localization (GO:0051303) | 2.99427667 |
| 163 | polyamine biosynthetic process (GO:0006596) | 2.96569740 |
| 164 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.96411629 |
| 165 | B cell receptor signaling pathway (GO:0050853) | 2.95969886 |
| 166 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.95573893 |
| 167 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.95573893 |
| 168 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.95534508 |
| 169 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93176034 |
| 170 | modulation by symbiont of host immune response (GO:0052553) | 2.93176034 |
| 171 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93176034 |
| 172 | modulation by symbiont of host defense response (GO:0052031) | 2.93176034 |
| 173 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93176034 |
| 174 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93176034 |
| 175 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91806658 |
| 176 | positive regulation of coagulation (GO:0050820) | 2.90089727 |
| 177 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89620089 |
| 178 | defense response to Gram-positive bacterium (GO:0050830) | 2.88364850 |
| 179 | detection of bacterium (GO:0016045) | 2.87862495 |
| 180 | termination of signal transduction (GO:0023021) | 2.87289668 |
| 181 | B cell mediated immunity (GO:0019724) | 2.87168192 |
| 182 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.86991166 |
| 183 | regulation of lipoprotein metabolic process (GO:0050746) | 2.86810283 |
| 184 | hepatocyte apoptotic process (GO:0097284) | 2.86122705 |
| 185 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.83734482 |
| 186 | regulation of megakaryocyte differentiation (GO:0045652) | 2.83284923 |
| 187 | negative regulation of heart rate (GO:0010459) | 2.83102814 |
| 188 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81161959 |
| 189 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.80729643 |
| 190 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80678874 |
| 191 | purinergic receptor signaling pathway (GO:0035587) | 2.80366989 |
| 192 | vesicle targeting (GO:0006903) | 2.77851673 |
| 193 | dendritic cell chemotaxis (GO:0002407) | 2.77266345 |
| 194 | positive regulation of B cell differentiation (GO:0045579) | 2.77100771 |
| 195 | positive regulation of mast cell degranulation (GO:0043306) | 2.75581227 |
| 196 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75581227 |
| 197 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.74483043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.24969722 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.41960795 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.28882138 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.74832622 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57976973 |
| 6 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.38884748 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07178128 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.98104748 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.92072245 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87153886 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.84285949 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.80674144 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.74989084 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70407541 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67131347 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66261088 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63908660 |
| 18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.61564243 |
| 19 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.52447406 |
| 20 | GATA2_19941826_ChIP-Seq_K562_Human | 2.46050056 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.41344692 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.39712366 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32599860 |
| 24 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.30040159 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29910783 |
| 26 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.29029107 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24722251 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.21569275 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.21514081 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18143783 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16030813 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14952885 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11929347 |
| 34 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.10442155 |
| 35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.09622745 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08372615 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07703191 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 12.3000569 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82606079 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79467086 |
| 41 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.79225773 |
| 42 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.75282948 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75231087 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74410665 |
| 45 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73689691 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71981294 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70467069 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.70429768 |
| 49 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.65960288 |
| 50 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61456313 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60696717 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60139413 |
| 53 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58910003 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58143408 |
| 55 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.57444585 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56631617 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.55588798 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54482494 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53739842 |
| 60 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51779769 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.50151437 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49776666 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.49054686 |
| 64 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.46362236 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.46075652 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45556227 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45193133 |
| 68 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45132913 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.44753310 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44582021 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43672489 |
| 72 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.42256912 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.40209908 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40079247 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.39955401 |
| 76 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.39532944 |
| 77 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.38898091 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.38773385 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37237032 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.37133176 |
| 81 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.36583632 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.35986030 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34971680 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30009490 |
| 85 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29149376 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.28476856 |
| 87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26021609 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25795411 |
| 89 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.25528204 |
| 90 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24875100 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24844040 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24789732 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24193324 |
| 94 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22886891 |
| 95 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21477199 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20902252 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19641723 |
| 98 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19453262 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17618212 |
| 100 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17348326 |
| 101 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16890095 |
| 102 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16527793 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.15053021 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13997207 |
| 105 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12844230 |
| 106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11838082 |
| 107 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.11218706 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09251788 |
| 109 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09103455 |
| 110 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.08435121 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07898253 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07510792 |
| 113 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07204387 |
| 114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06446729 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06124267 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05998939 |
| 117 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05092219 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04845121 |
| 119 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04024229 |
| 120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03004111 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02678183 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01646603 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01566000 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01541989 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01459037 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00139926 |
| 127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99026139 |
| 128 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98657397 |
| 129 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96326752 |
| 130 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95950185 |
| 131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95934391 |
| 132 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94741322 |
| 133 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.94618486 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94441571 |
| 135 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93585615 |
| 136 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93299496 |
| 137 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92089044 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91043164 |
| 139 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90960416 |
| 140 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90642723 |
| 141 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90606689 |
| 142 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90581821 |
| 143 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90419816 |
| 144 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90264422 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89629438 |
| 146 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89064716 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88789288 |
| 148 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.88285718 |
| 149 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85891937 |
| 150 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83144283 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79832813 |
| 152 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.79275591 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79197329 |
| 154 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78905655 |
| 155 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77597248 |
| 156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76915482 |
| 157 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.76889206 |
| 158 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76581865 |
| 159 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76581865 |
| 160 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76070471 |
| 161 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76011052 |
| 162 | * MYC_18940864_ChIP-ChIP_HL60_Human | 0.75161255 |
| 163 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.74718649 |
| 164 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74352374 |
| 165 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73553229 |
| 166 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73275282 |
| 167 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73192175 |
| 168 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.72856271 |
| 169 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71776682 |
| 170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71759913 |
| 171 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.71358131 |
| 172 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69305747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.85336555 |
| 2 | MP0010094_abnormal_chromosome_stability | 5.20475147 |
| 3 | MP0003693_abnormal_embryo_hatching | 4.51085228 |
| 4 | MP0003724_increased_susceptibility_to | 4.46325120 |
| 5 | MP0003111_abnormal_nucleus_morphology | 4.44238569 |
| 6 | MP0003077_abnormal_cell_cycle | 4.03351048 |
| 7 | MP0008004_abnormal_stomach_pH | 3.90272092 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.69217808 |
| 9 | MP0010307_abnormal_tumor_latency | 3.33178759 |
| 10 | MP0008057_abnormal_DNA_replication | 3.28305884 |
| 11 | MP0003303_peritoneal_inflammation | 2.99613950 |
| 12 | MP0008058_abnormal_DNA_repair | 2.97846670 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.67199771 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.61419509 |
| 15 | MP0005083_abnormal_biliary_tract | 2.56743260 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.54287602 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.41810046 |
| 18 | MP0000350_abnormal_cell_proliferation | 2.29126430 |
| 19 | MP0000490_abnormal_crypts_of | 2.17382792 |
| 20 | MP0001730_embryonic_growth_arrest | 2.14587462 |
| 21 | MP0003123_paternal_imprinting | 2.11232797 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.09005850 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 2.05443278 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.01013463 |
| 25 | MP0003828_pulmonary_edema | 1.97735619 |
| 26 | MP0004147_increased_porphyrin_level | 1.96801984 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.90251687 |
| 28 | MP0000343_altered_response_to | 1.88527954 |
| 29 | MP0004510_myositis | 1.87877551 |
| 30 | MP0006054_spinal_hemorrhage | 1.81056658 |
| 31 | MP0004947_skin_inflammation | 1.74773466 |
| 32 | MP0008260_abnormal_autophagy | 1.74185479 |
| 33 | MP0002723_abnormal_immune_serum | 1.73879455 |
| 34 | MP0002419_abnormal_innate_immunity | 1.73393560 |
| 35 | MP0002132_abnormal_respiratory_system | 1.72907206 |
| 36 | MP0001851_eye_inflammation | 1.67063539 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.66136833 |
| 38 | MP0001697_abnormal_embryo_size | 1.60846773 |
| 39 | MP0002019_abnormal_tumor_incidence | 1.60075638 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.59586221 |
| 41 | MP0005025_abnormal_response_to | 1.58197170 |
| 42 | MP0002080_prenatal_lethality | 1.55849360 |
| 43 | MP0003786_premature_aging | 1.54508002 |
| 44 | MP0002086_abnormal_extraembryonic_tissu | 1.54200589 |
| 45 | MP0001672_abnormal_embryogenesis/_devel | 1.54029657 |
| 46 | MP0005380_embryogenesis_phenotype | 1.54029657 |
| 47 | MP0004197_abnormal_fetal_growth/weight/ | 1.53456806 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.52952268 |
| 49 | MP0003866_abnormal_defecation | 1.51334907 |
| 50 | MP0000313_abnormal_cell_death | 1.50543744 |
| 51 | MP0009764_decreased_sensitivity_to | 1.49998834 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.48272634 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.48272634 |
| 54 | MP0002084_abnormal_developmental_patter | 1.46920629 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.45577679 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.44193050 |
| 57 | MP0002085_abnormal_embryonic_tissue | 1.44181445 |
| 58 | MP0003121_genomic_imprinting | 1.41530849 |
| 59 | MP0001293_anophthalmia | 1.41209124 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.40940391 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.40297840 |
| 62 | MP0004130_abnormal_muscle_cell | 1.39150777 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.38827150 |
| 64 | MP0002398_abnormal_bone_marrow | 1.38131404 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.37413142 |
| 66 | MP0005387_immune_system_phenotype | 1.35603106 |
| 67 | MP0001790_abnormal_immune_system | 1.35603106 |
| 68 | MP0002722_abnormal_immune_system | 1.34265946 |
| 69 | MP0003984_embryonic_growth_retardation | 1.32034162 |
| 70 | MP0009785_altered_susceptibility_to | 1.31911896 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.30537943 |
| 72 | MP0002088_abnormal_embryonic_growth/wei | 1.29162854 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.26426489 |
| 74 | MP0009763_increased_sensitivity_to | 1.25128385 |
| 75 | MP0000249_abnormal_blood_vessel | 1.22287471 |
| 76 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21631189 |
| 77 | MP0000230_abnormal_systemic_arterial | 1.18907023 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.18315323 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.18187927 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.17704895 |
| 81 | MP0003638_abnormal_response/metabolism_ | 1.17019170 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.15876005 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.14224580 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 1.12856002 |
| 85 | MP0000372_irregular_coat_pigmentation | 1.12172574 |
| 86 | MP0004084_abnormal_cardiac_muscle | 1.11712914 |
| 87 | MP0001663_abnormal_digestive_system | 1.11090340 |
| 88 | MP0003890_abnormal_embryonic-extraembry | 1.08238524 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 1.07942343 |
| 90 | MP0004381_abnormal_hair_follicle | 1.06695835 |
| 91 | MP0000371_diluted_coat_color | 1.06083417 |
| 92 | MP0002429_abnormal_blood_cell | 1.05035212 |
| 93 | MP0009697_abnormal_copulation | 1.00227515 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.99163695 |
| 95 | MP0002006_tumorigenesis | 0.98494391 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.97318107 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.96878244 |
| 98 | MP0000685_abnormal_immune_system | 0.96776626 |
| 99 | MP0002075_abnormal_coat/hair_pigmentati | 0.96206321 |
| 100 | MP0002405_respiratory_system_inflammati | 0.95712736 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.94969226 |
| 102 | MP0003252_abnormal_bile_duct | 0.94291215 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.92056373 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.91153147 |
| 105 | MP0000537_abnormal_urethra_morphology | 0.90943950 |
| 106 | MP0005410_abnormal_fertilization | 0.90485407 |
| 107 | MP0003879_abnormal_hair_cell | 0.89991302 |
| 108 | MP0001800_abnormal_humoral_immune | 0.89135162 |
| 109 | MP0002111_abnormal_tail_morphology | 0.88792260 |
| 110 | MP0002092_abnormal_eye_morphology | 0.88409631 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.87701833 |
| 112 | MP0008874_decreased_physiological_sensi | 0.86488148 |
| 113 | MP0004883_abnormal_blood_vessel | 0.86276428 |
| 114 | MP0000716_abnormal_immune_system | 0.86200686 |
| 115 | MP0005384_cellular_phenotype | 0.85903741 |
| 116 | MP0001915_intracranial_hemorrhage | 0.85431359 |
| 117 | MP0005621_abnormal_cell_physiology | 0.84627874 |
| 118 | MP0000358_abnormal_cell_content/ | 0.84405305 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.84318783 |
| 120 | MP0003937_abnormal_limbs/digits/tail_de | 0.83710531 |
| 121 | MP0003091_abnormal_cell_migration | 0.80716870 |
| 122 | MP0005451_abnormal_body_composition | 0.80619455 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.80214831 |
| 124 | MP0002009_preneoplasia | 0.80205837 |
| 125 | MP0001835_abnormal_antigen_presentation | 0.79576917 |
| 126 | MP0008770_decreased_survivor_rate | 0.79209493 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.78129851 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.77178708 |
| 129 | MP0008872_abnormal_physiological_respon | 0.76383531 |
| 130 | MP0005174_abnormal_tail_pigmentation | 0.75508648 |
| 131 | MP0010329_abnormal_lipoprotein_level | 0.75396928 |
| 132 | MP0002210_abnormal_sex_determination | 0.75180710 |
| 133 | MP0005023_abnormal_wound_healing | 0.74762680 |
| 134 | MP0003075_altered_response_to | 0.73482461 |
| 135 | MP0002420_abnormal_adaptive_immunity | 0.73459192 |
| 136 | MP0000733_abnormal_muscle_development | 0.72815334 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.72521096 |
| 138 | MP0005409_darkened_coat_color | 0.71997358 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.71961778 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.71665890 |
| 141 | MP0001819_abnormal_immune_cell | 0.71631494 |
| 142 | MP0001145_abnormal_male_reproductive | 0.71190601 |
| 143 | MP0008469_abnormal_protein_level | 0.69199217 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.68614416 |
| 145 | MP0001186_pigmentation_phenotype | 0.67375854 |
| 146 | MP0002697_abnormal_eye_size | 0.67303386 |
| 147 | MP0005501_abnormal_skin_physiology | 0.65674733 |
| 148 | MP0003718_maternal_effect | 0.65258373 |
| 149 | MP0004484_altered_response_of | 0.64865852 |
| 150 | MP0003448_altered_tumor_morphology | 0.64817221 |
| 151 | MP0008775_abnormal_heart_ventricle | 0.64301719 |
| 152 | MP0003045_fibrosis | 0.64289422 |
| 153 | MP0001661_extended_life_span | 0.64090456 |
| 154 | MP0009278_abnormal_bone_marrow | 0.63846956 |
| 155 | MP0005310_abnormal_salivary_gland | 0.63515974 |
| 156 | MP0005075_abnormal_melanosome_morpholog | 0.63088879 |
| 157 | MP0001929_abnormal_gametogenesis | 0.62908647 |
| 158 | MP0000858_altered_metastatic_potential | 0.62172571 |
| 159 | MP0003436_decreased_susceptibility_to | 0.61802762 |
| 160 | MP0001873_stomach_inflammation | 0.60140931 |
| 161 | MP0005671_abnormal_response_to | 0.59340854 |
| 162 | MP0009703_decreased_birth_body | 0.59261804 |
| 163 | MP0002102_abnormal_ear_morphology | 0.57954944 |
| 164 | MP0003119_abnormal_digestive_system | 0.57089733 |
| 165 | MP0000653_abnormal_sex_gland | 0.56081422 |
| 166 | MP0010155_abnormal_intestine_physiology | 0.55433143 |
| 167 | MP0002925_abnormal_cardiovascular_devel | 0.55419319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.86145745 |
| 2 | Increased mean platelet volume (HP:0011877) | 8.87059096 |
| 3 | Menorrhagia (HP:0000132) | 8.67944280 |
| 4 | Abnormal platelet volume (HP:0011876) | 8.63488138 |
| 5 | Petechiae (HP:0000967) | 8.31574746 |
| 6 | Purpura (HP:0000979) | 7.30649309 |
| 7 | Epistaxis (HP:0000421) | 6.98794226 |
| 8 | Gingival bleeding (HP:0000225) | 6.34145485 |
| 9 | Reticulocytopenia (HP:0001896) | 5.26253464 |
| 10 | Impaired platelet aggregation (HP:0003540) | 5.17134391 |
| 11 | Abnormal platelet function (HP:0011869) | 5.17134391 |
| 12 | Spontaneous hematomas (HP:0007420) | 5.10394403 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.59953419 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.33588487 |
| 15 | Chromsome breakage (HP:0040012) | 4.14733696 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.92907952 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.85469750 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.84628021 |
| 19 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.70006845 |
| 20 | Abnormality of chromosome stability (HP:0003220) | 3.68350769 |
| 21 | Birth length less than 3rd percentile (HP:0003561) | 3.63284459 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.59693021 |
| 23 | Colon cancer (HP:0003003) | 3.58535745 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.50819541 |
| 25 | Cutaneous melanoma (HP:0012056) | 3.47276598 |
| 26 | Pallor (HP:0000980) | 3.40441604 |
| 27 | Agnosia (HP:0010524) | 3.38040628 |
| 28 | Conjunctival telangiectasia (HP:0000524) | 3.36491498 |
| 29 | Ependymoma (HP:0002888) | 3.31053803 |
| 30 | Dyschromatopsia (HP:0007641) | 3.26477607 |
| 31 | Poikilocytosis (HP:0004447) | 3.25280743 |
| 32 | Macrocytic anemia (HP:0001972) | 3.23739973 |
| 33 | Selective tooth agenesis (HP:0001592) | 3.22248245 |
| 34 | Medulloblastoma (HP:0002885) | 3.19972737 |
| 35 | Bruising susceptibility (HP:0000978) | 3.12642598 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.12248699 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 3.08431558 |
| 38 | Abnormality of reticulocytes (HP:0004312) | 3.07939819 |
| 39 | Rhabdomyosarcoma (HP:0002859) | 3.04253001 |
| 40 | Basal cell carcinoma (HP:0002671) | 3.02912695 |
| 41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.02566458 |
| 42 | Myelodysplasia (HP:0002863) | 2.95947303 |
| 43 | Impulsivity (HP:0100710) | 2.92987213 |
| 44 | Meckel diverticulum (HP:0002245) | 2.88866510 |
| 45 | Thrombocytosis (HP:0001894) | 2.87608537 |
| 46 | Obstructive lung disease (HP:0006536) | 2.85937882 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85937882 |
| 48 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.84108370 |
| 49 | Abnormality of the ileum (HP:0001549) | 2.80413789 |
| 50 | Abnormality of the preputium (HP:0100587) | 2.80327142 |
| 51 | 11 pairs of ribs (HP:0000878) | 2.71615249 |
| 52 | Absent thumb (HP:0009777) | 2.71159680 |
| 53 | Poikiloderma (HP:0001029) | 2.62589053 |
| 54 | Encephalitis (HP:0002383) | 2.61829712 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.61288891 |
| 56 | Aplastic anemia (HP:0001915) | 2.59199296 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.58910327 |
| 58 | Astrocytoma (HP:0009592) | 2.58244744 |
| 59 | Abnormality of the astrocytes (HP:0100707) | 2.58244744 |
| 60 | Arterial thrombosis (HP:0004420) | 2.54822915 |
| 61 | Duodenal stenosis (HP:0100867) | 2.54464153 |
| 62 | Small intestinal stenosis (HP:0012848) | 2.54464153 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.52190561 |
| 64 | Sloping forehead (HP:0000340) | 2.50960524 |
| 65 | Amaurosis fugax (HP:0100576) | 2.50752735 |
| 66 | Papillary thyroid carcinoma (HP:0002895) | 2.48732218 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.47121799 |
| 68 | Paralysis (HP:0003470) | 2.46011719 |
| 69 | Prominent nose (HP:0000448) | 2.45357926 |
| 70 | Acanthocytosis (HP:0001927) | 2.44679458 |
| 71 | Cafe-au-lait spot (HP:0000957) | 2.44299871 |
| 72 | Squamous cell carcinoma (HP:0002860) | 2.43737626 |
| 73 | Stomatitis (HP:0010280) | 2.42504532 |
| 74 | Abnormal pupillary function (HP:0007686) | 2.41345603 |
| 75 | Freckling (HP:0001480) | 2.40467951 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.40359461 |
| 77 | Polycythemia (HP:0001901) | 2.40343651 |
| 78 | Increased density of long bones (HP:0006392) | 2.39837976 |
| 79 | Colitis (HP:0002583) | 2.38659006 |
| 80 | Increased IgM level (HP:0003496) | 2.37864121 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.37459060 |
| 82 | Neoplasm of the oral cavity (HP:0100649) | 2.35274839 |
| 83 | Joint swelling (HP:0001386) | 2.34229605 |
| 84 | IgM deficiency (HP:0002850) | 2.34179517 |
| 85 | Glioma (HP:0009733) | 2.33673813 |
| 86 | High pitched voice (HP:0001620) | 2.32369190 |
| 87 | Joint hemorrhage (HP:0005261) | 2.30677944 |
| 88 | Volvulus (HP:0002580) | 2.30099968 |
| 89 | Abnormality of the carotid arteries (HP:0005344) | 2.26778653 |
| 90 | Short 4th metacarpal (HP:0010044) | 2.26112470 |
| 91 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.26112470 |
| 92 | Neoplasm of the pancreas (HP:0002894) | 2.25101116 |
| 93 | Entropion (HP:0000621) | 2.22932982 |
| 94 | Patellar aplasia (HP:0006443) | 2.21470691 |
| 95 | Increased serum ferritin (HP:0003281) | 2.20889265 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.19929559 |
| 97 | Chest pain (HP:0100749) | 2.19218141 |
| 98 | Abnormal auditory evoked potentials (HP:0006958) | 2.17296390 |
| 99 | Neoplasm of striated muscle (HP:0009728) | 2.16020257 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 2.15877503 |
| 101 | Tinnitus (HP:0000360) | 2.13947067 |
| 102 | Abnormality of the labia minora (HP:0012880) | 2.13643730 |
| 103 | Increased nuchal translucency (HP:0010880) | 2.13025359 |
| 104 | Abnormality of the duodenum (HP:0002246) | 2.12893179 |
| 105 | Biliary tract neoplasm (HP:0100574) | 2.11524932 |
| 106 | Oral leukoplakia (HP:0002745) | 2.11117650 |
| 107 | Bone marrow hypocellularity (HP:0005528) | 2.10939444 |
| 108 | Lymphoma (HP:0002665) | 2.09156870 |
| 109 | IgA deficiency (HP:0002720) | 2.08847044 |
| 110 | Abnormality of DNA repair (HP:0003254) | 2.08102381 |
| 111 | Premature graying of hair (HP:0002216) | 2.06228904 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05053548 |
| 113 | Meningitis (HP:0001287) | 2.04106274 |
| 114 | Proximal placement of thumb (HP:0009623) | 2.02992619 |
| 115 | Dysautonomia (HP:0002459) | 2.01718648 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01171838 |
| 117 | Absent radius (HP:0003974) | 2.00932999 |
| 118 | Breast hypoplasia (HP:0003187) | 2.00730686 |
| 119 | Spastic diplegia (HP:0001264) | 2.00719011 |
| 120 | Gingivitis (HP:0000230) | 2.00516206 |
| 121 | Deviation of the thumb (HP:0009603) | 2.00115269 |
| 122 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.99328168 |
| 123 | Abnormal number of incisors (HP:0011064) | 1.98166847 |
| 124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97753379 |
| 125 | Missing ribs (HP:0000921) | 1.97334403 |
| 126 | Ectopic kidney (HP:0000086) | 1.96541920 |
| 127 | Hypopigmentation of the fundus (HP:0007894) | 1.95317464 |
| 128 | Xanthomatosis (HP:0000991) | 1.94271014 |
| 129 | T lymphocytopenia (HP:0005403) | 1.94228053 |
| 130 | Abnormality of lateral ventricle (HP:0030047) | 1.94226547 |
| 131 | Episodic fever (HP:0001954) | 1.93786051 |
| 132 | Upper limb muscle weakness (HP:0003484) | 1.92982718 |
| 133 | Clubbing of toes (HP:0100760) | 1.92063876 |
| 134 | Acute lymphatic leukemia (HP:0006721) | 1.91436129 |
| 135 | Recurrent fungal infections (HP:0002841) | 1.91063848 |
| 136 | Myositis (HP:0100614) | 1.90949044 |
| 137 | Atresia of the external auditory canal (HP:0000413) | 1.90818648 |
| 138 | Myocardial infarction (HP:0001658) | 1.89496270 |
| 139 | Duplicated collecting system (HP:0000081) | 1.87482811 |
| 140 | Sandal gap (HP:0001852) | 1.87055256 |
| 141 | Tracheoesophageal fistula (HP:0002575) | 1.86004495 |
| 142 | Reticulocytosis (HP:0001923) | 1.85138393 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.84333073 |
| 144 | Vasculitis (HP:0002633) | 1.84163948 |
| 145 | Orchitis (HP:0100796) | 1.83644752 |
| 146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83403775 |
| 147 | Granulocytopenia (HP:0001913) | 1.83349960 |
| 148 | Abnormal lung lobation (HP:0002101) | 1.83009757 |
| 149 | Absent forearm bone (HP:0003953) | 1.81606247 |
| 150 | Aplasia involving forearm bones (HP:0009822) | 1.81606247 |
| 151 | Retrobulbar optic neuritis (HP:0100654) | 1.80812027 |
| 152 | Optic neuritis (HP:0100653) | 1.80812027 |
| 153 | Leiomyosarcoma (HP:0100243) | 1.80272027 |
| 154 | Uterine leiomyosarcoma (HP:0002891) | 1.80272027 |
| 155 | Neoplasm of the colon (HP:0100273) | 1.80117021 |
| 156 | B lymphocytopenia (HP:0010976) | 1.79980664 |
| 157 | Abnormality of B cell number (HP:0010975) | 1.79980664 |
| 158 | Acute hepatic failure (HP:0006554) | 1.79853314 |
| 159 | Urticaria (HP:0001025) | 1.79737878 |
| 160 | Spontaneous abortion (HP:0005268) | 1.79648005 |
| 161 | Osteomyelitis (HP:0002754) | 1.77827034 |
| 162 | Triphalangeal thumb (HP:0001199) | 1.77695300 |
| 163 | Recurrent skin infections (HP:0001581) | 1.77258237 |
| 164 | Leukocytosis (HP:0001974) | 1.76618154 |
| 165 | Microcytic anemia (HP:0001935) | 1.75910669 |
| 166 | Cellulitis (HP:0100658) | 1.75539728 |
| 167 | Slender long bone (HP:0003100) | 1.75060775 |
| 168 | Short thumb (HP:0009778) | 1.74689380 |
| 169 | Leukopenia (HP:0001882) | 1.74042782 |
| 170 | Thrombophlebitis (HP:0004418) | 1.73848813 |
| 171 | Distal lower limb amyotrophy (HP:0008944) | 1.73202835 |
| 172 | Mitral stenosis (HP:0001718) | 1.72191182 |
| 173 | Abnormality of the prostate (HP:0008775) | 1.71953977 |
| 174 | Pulmonary embolism (HP:0002204) | 1.71933208 |
| 175 | Ovarian neoplasm (HP:0100615) | 1.70927596 |
| 176 | Recurrent viral infections (HP:0004429) | 1.69891134 |
| 177 | Microretrognathia (HP:0000308) | 1.69760371 |
| 178 | Gastrointestinal carcinoma (HP:0002672) | 1.69678786 |
| 179 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.69678786 |
| 180 | Thyroiditis (HP:0100646) | 1.69036593 |
| 181 | Cellular immunodeficiency (HP:0005374) | 1.67150262 |
| 182 | Abnormality of the calcaneus (HP:0008364) | 1.65150902 |
| 183 | Abnormality of the renal collecting system (HP:0004742) | 1.64823647 |
| 184 | Mucosal telangiectasiae (HP:0100579) | 1.64510197 |
| 185 | Vertigo (HP:0002321) | 1.64173907 |
| 186 | Bladder carcinoma (HP:0002862) | 1.64063820 |
| 187 | Bladder neoplasm (HP:0009725) | 1.64063820 |
| 188 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.63334981 |
| 189 | Muscle fibrillation (HP:0010546) | 1.62224966 |
| 190 | Thyroid carcinoma (HP:0002890) | 1.60298179 |
| 191 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.59812373 |
| 192 | Eosinophilia (HP:0001880) | 1.59211186 |
| 193 | Hypertriglyceridemia (HP:0002155) | 1.58533625 |
| 194 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.56408552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 9.00294575 |
| 2 | ZAK | 5.55160011 |
| 3 | RIPK4 | 5.30982356 |
| 4 | VRK1 | 3.74100910 |
| 5 | CDC7 | 3.51175249 |
| 6 | MST4 | 3.24953541 |
| 7 | BMX | 2.95432808 |
| 8 | WEE1 | 2.75000624 |
| 9 | STK4 | 2.67002647 |
| 10 | BLK | 2.63187728 |
| 11 | RPS6KA5 | 2.44642995 |
| 12 | NEK2 | 2.32405619 |
| 13 | BUB1 | 2.32266280 |
| 14 | SCYL2 | 2.25877153 |
| 15 | SYK | 2.11609753 |
| 16 | PIK3CG | 2.10252823 |
| 17 | EEF2K | 2.03069009 |
| 18 | BMPR2 | 2.00400310 |
| 19 | MYLK | 1.93027706 |
| 20 | SRPK1 | 1.92624930 |
| 21 | ZAP70 | 1.85716791 |
| 22 | EIF2AK1 | 1.80952814 |
| 23 | AURKB | 1.76954959 |
| 24 | DYRK3 | 1.72803333 |
| 25 | MAP3K10 | 1.69600629 |
| 26 | RPS6KB2 | 1.68492756 |
| 27 | PTK2B | 1.67371060 |
| 28 | HCK | 1.64097920 |
| 29 | FES | 1.62603816 |
| 30 | MAP3K8 | 1.61588503 |
| 31 | FGR | 1.58353470 |
| 32 | ACVR1B | 1.57368898 |
| 33 | PIM1 | 1.57302260 |
| 34 | NME2 | 1.49786046 |
| 35 | CHEK2 | 1.46043986 |
| 36 | CDK9 | 1.45372595 |
| 37 | NEK1 | 1.44031873 |
| 38 | CSK | 1.40531306 |
| 39 | TAOK3 | 1.38101586 |
| 40 | FLT3 | 1.32780974 |
| 41 | IRAK4 | 1.32710040 |
| 42 | TTK | 1.29702523 |
| 43 | PLK1 | 1.28343238 |
| 44 | PKN2 | 1.26097853 |
| 45 | ATR | 1.25722626 |
| 46 | EPHA3 | 1.24876529 |
| 47 | GRK5 | 1.22819596 |
| 48 | CDK12 | 1.15434240 |
| 49 | AURKA | 1.09606771 |
| 50 | PASK | 1.08952515 |
| 51 | DAPK3 | 1.06404418 |
| 52 | RET | 1.04737107 |
| 53 | TGFBR1 | 1.02033850 |
| 54 | IRAK1 | 1.00531116 |
| 55 | BRSK2 | 0.99565649 |
| 56 | MAP3K3 | 0.97973348 |
| 57 | CDK4 | 0.96833218 |
| 58 | TNK2 | 0.94979077 |
| 59 | MAP3K2 | 0.94585566 |
| 60 | PIM2 | 0.93948172 |
| 61 | CDK7 | 0.93214408 |
| 62 | STK10 | 0.92584776 |
| 63 | JAK3 | 0.90967868 |
| 64 | IKBKB | 0.85099295 |
| 65 | EIF2AK3 | 0.81857389 |
| 66 | JAK1 | 0.81650366 |
| 67 | GRK6 | 0.80591550 |
| 68 | LMTK2 | 0.79912232 |
| 69 | EPHA2 | 0.78793184 |
| 70 | CHEK1 | 0.78754084 |
| 71 | YES1 | 0.77363094 |
| 72 | PLK3 | 0.76150061 |
| 73 | MAP3K6 | 0.75897722 |
| 74 | TESK2 | 0.75667897 |
| 75 | TSSK6 | 0.73501117 |
| 76 | STK24 | 0.73200171 |
| 77 | ITK | 0.73021726 |
| 78 | DYRK1B | 0.71564420 |
| 79 | PDK1 | 0.71089433 |
| 80 | ATM | 0.68651070 |
| 81 | LCK | 0.68033481 |
| 82 | TTN | 0.67679979 |
| 83 | LRRK2 | 0.67308781 |
| 84 | MAP3K5 | 0.67125476 |
| 85 | PAK4 | 0.65333341 |
| 86 | MAP3K1 | 0.63885776 |
| 87 | TXK | 0.62717163 |
| 88 | PDPK1 | 0.62338105 |
| 89 | EPHB1 | 0.61980353 |
| 90 | CDK2 | 0.60378026 |
| 91 | CCNB1 | 0.59594582 |
| 92 | AKT2 | 0.56967313 |
| 93 | PLK4 | 0.56725412 |
| 94 | MKNK1 | 0.56610211 |
| 95 | FER | 0.55016016 |
| 96 | KSR2 | 0.53667503 |
| 97 | MELK | 0.53630768 |
| 98 | TYK2 | 0.53577265 |
| 99 | RPS6KA4 | 0.53539897 |
| 100 | CDK6 | 0.53517383 |
| 101 | CSF1R | 0.52751077 |
| 102 | BRSK1 | 0.50687025 |
| 103 | MAPK12 | 0.50300425 |
| 104 | PKN1 | 0.48823500 |
| 105 | IRAK2 | 0.48522061 |
| 106 | TAOK2 | 0.48220389 |
| 107 | ERBB2 | 0.47969200 |
| 108 | MAP2K4 | 0.47890057 |
| 109 | TAOK1 | 0.47164587 |
| 110 | PRKCQ | 0.46051808 |
| 111 | CAMKK2 | 0.44906089 |
| 112 | FYN | 0.44766161 |
| 113 | PDGFRB | 0.44602577 |
| 114 | IRAK3 | 0.43801632 |
| 115 | CDK1 | 0.42760127 |
| 116 | MAP3K11 | 0.42291281 |
| 117 | PRPF4B | 0.41349676 |
| 118 | MAP4K1 | 0.40447533 |
| 119 | MAP2K1 | 0.40100921 |
| 120 | STK16 | 0.38823693 |
| 121 | MAPKAPK3 | 0.38293860 |
| 122 | FGFR3 | 0.38242378 |
| 123 | EIF2AK2 | 0.38126666 |
| 124 | ADRBK1 | 0.38061862 |
| 125 | PAK1 | 0.37888269 |
| 126 | NLK | 0.37553801 |
| 127 | IKBKE | 0.37052230 |
| 128 | CSNK2A2 | 0.35578641 |
| 129 | BRD4 | 0.33897920 |
| 130 | MAP2K3 | 0.32939317 |
| 131 | SGK3 | 0.32830361 |
| 132 | PRKACG | 0.32784305 |
| 133 | PRKD1 | 0.32632588 |
| 134 | NEK9 | 0.31878879 |
| 135 | RAF1 | 0.31584210 |
| 136 | PRKCD | 0.30591903 |
| 137 | MKNK2 | 0.29957809 |
| 138 | SGK2 | 0.29668981 |
| 139 | STK3 | 0.29564789 |
| 140 | CAMK1D | 0.29527890 |
| 141 | TRIB3 | 0.29229994 |
| 142 | ALK | 0.28086565 |
| 143 | TEC | 0.27089937 |
| 144 | PRKDC | 0.26505007 |
| 145 | BTK | 0.24893876 |
| 146 | CSNK1D | 0.24857909 |
| 147 | KIT | 0.24583499 |
| 148 | CLK1 | 0.23161824 |
| 149 | MARK3 | 0.23005744 |
| 150 | PRKAA1 | 0.22082999 |
| 151 | CSNK2A1 | 0.21976992 |
| 152 | LYN | 0.21204012 |
| 153 | ILK | 0.20876414 |
| 154 | PAK2 | 0.20668737 |
| 155 | JAK2 | 0.19734967 |
| 156 | MTOR | 0.19233268 |
| 157 | MAPK11 | 0.16242947 |
| 158 | RPS6KB1 | 0.15986754 |
| 159 | AKT1 | 0.15690288 |
| 160 | MATK | 0.15431004 |
| 161 | MAPK14 | 0.15006862 |
| 162 | KDR | 0.13938729 |
| 163 | PRKCI | 0.13681320 |
| 164 | RPS6KL1 | 0.12314605 |
| 165 | RPS6KC1 | 0.12314605 |
| 166 | MET | 0.11098087 |
| 167 | TRPM7 | 0.09803411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 9.18971771 |
| 2 | * Alcoholism_Homo sapiens_hsa05034 | 5.15331212 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.06917392 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.41762657 |
| 5 | Viral carcinogenesis_Homo sapiens_hsa05203 | 2.85263354 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.82768635 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.51159447 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.41512752 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.26806498 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.26074451 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.23937762 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.18979654 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.16631572 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.09735423 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.03820475 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.00012046 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.90902304 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.86186837 |
| 19 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.68918398 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58962506 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.57802912 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.56173483 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.55960415 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53826878 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47184953 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41871621 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38839826 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23901858 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11514038 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10786161 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10332745 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.09650752 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08286208 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.07858662 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.02819039 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01399301 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97444427 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97000591 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 0.95462230 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 0.95437502 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94324354 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 0.92788796 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.89536422 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.89535218 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87225371 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79338520 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78637940 |
| 48 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.78462581 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78447061 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78234447 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77806417 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77534379 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76670171 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76169823 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74829914 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73831028 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73268454 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71447334 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 0.71238810 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70628083 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68414499 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66659347 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65196833 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64816766 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64372417 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62711387 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62203436 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60244432 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58966788 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58210209 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56938954 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56890526 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55121669 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54502093 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.54276085 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.53570476 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.53229857 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52609198 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52565832 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52011347 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51982210 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50779217 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50149129 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.47709029 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.47280023 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47143875 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.45849587 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.45737501 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45578922 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45078953 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44348155 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43836807 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42687238 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.42414615 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41434924 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41428129 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41201241 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41056417 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41014205 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40204163 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38546241 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38216906 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37933321 |
| 104 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37012280 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36930701 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.36465055 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.36408196 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35783386 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35491523 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35389919 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34575343 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34355890 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34077654 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33605879 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33447318 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33324059 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.32910355 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32672361 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32546295 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29670893 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28905832 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26526072 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26405285 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23849288 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23545212 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.23067348 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.22548179 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21794807 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21644735 |
| 130 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19627543 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19256826 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19094643 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.18778165 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18252740 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17083024 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.16932870 |
| 137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16566117 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.16495908 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16422687 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14246422 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.14162288 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.14021055 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.13873840 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.13281671 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.13002352 |
| 146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.12466781 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11788902 |
| 148 | Viral myocarditis_Homo sapiens_hsa05416 | 0.10326495 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09733660 |
| 150 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.09588828 |
| 151 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.08692998 |
| 152 | Platelet activation_Homo sapiens_hsa04611 | 0.08559168 |
| 153 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08373429 |
| 154 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.06722551 |
| 155 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06196562 |
| 156 | Malaria_Homo sapiens_hsa05144 | 0.05767439 |
| 157 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05679365 |
| 158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.04885415 |
| 159 | Glioma_Homo sapiens_hsa05214 | 0.04773399 |

